Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Clinical Characteristics, Real-world Treatment Pathways, and Outcomes of Patients With Moderate Rheumatoid Arthritis

NCT01557322 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT01557322
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01557322 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Clinical Characteristics, Real-world Treatment Pathways, and Outcomes of Patients With Moderate Rheumatoid Arthritis
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
October 31, 2011
Completion date
September 30, 2012
Enrollment
1,754 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis